Yan T - Search Results

1

High-expressing cystic fibrosis transmembrane conductance regulator interacts with histone deacetylase 2 to promote the development of Ph+ leukemia through the HDAC2-mediated PTEN pathway.

Yan T, Leng Y, Yang X, Gong Y, Sun H, Wang K, Xu W, Zheng Y, Naren D, Shi R. Yan T, et al. Leuk Res. 2017 Jun;57:9-19. doi: 10.1016/j.leukres.2017.02.004. Epub 2017 Feb 16. Leuk Res. 2017. PMID: 28235656

2

[Relationship of Cystic Fibrosis Transmembrane Conductance Regulator Expression with Clinical Features and Prognosis in Patients with Acute Leukemia].

Wang HF, Yang X, Liu XH, Naren DL, Sang LN, Yan TY, Zheng X, Li YR, Zhang NC, Gong YP. Wang HF, et al. Sichuan Da Xue Xue Bao Yi Xue Ban. 2019 May;50(3):420-424. Sichuan Da Xue Xue Bao Yi Xue Ban. 2019. PMID: 31631611 Chinese.

3

Ribavirin Inhibits the Activity of mTOR/eIF4E, ERK/Mnk1/eIF4E Signaling Pathway and Synergizes with Tyrosine Kinase Inhibitor Imatinib to Impair Bcr-Abl Mediated Proliferation and Apoptosis in Ph+ Leukemia.

Shi F, Len Y, Gong Y, Shi R, Yang X, Naren D, Yan T. Shi F, et al. Among authors: yan t. PLoS One. 2015 Aug 28;10(8):e0136746. doi: 10.1371/journal.pone.0136746. eCollection 2015. PLoS One. 2015. PMID: 26317515 Free PMC article.

4

Niemann-Pick disease type C1(NPC1) is involved in resistance against imatinib in the imatinib-resistant Ph+ acute lymphoblastic leukemia cell line SUP-B15/RI.

Naren D, Wu J, Gong Y, Yan T, Wang K, Xu W, Yang X, Shi F, Shi R. Naren D, et al. Among authors: yan t. Leuk Res. 2016 Mar;42:59-67. doi: 10.1016/j.leukres.2016.01.007. Epub 2016 Jan 16. Leuk Res. 2016. PMID: 26818574

5

High CFTR expression in Philadelphia chromosome-positive acute leukemia protects and maintains continuous activation of BCR-ABL and related signaling pathways in combination with PP2A.

Yang X, Yan T, Gong Y, Liu X, Sun H, Xu W, Wang C, Naren D, Zheng Y. Yang X, et al. Among authors: yan t. Oncotarget. 2017 Apr 11;8(15):24437-24448. doi: 10.18632/oncotarget.15510. Oncotarget. 2017. PMID: 28445932 Free PMC article.

6

[The Roles of Glut5 in Imatinib Resistance in the Ph⁺ Acute Lymphoblastic Leukemia Cell].

Yan TY, Naren DL, Gong YP. Yan TY, et al. Sichuan Da Xue Xue Bao Yi Xue Ban. 2017 May;48(3):389-393. Sichuan Da Xue Xue Bao Yi Xue Ban. 2017. PMID: 28616912 Chinese.

7

The antileukemia effect of metformin in the Philadelphia chromosome-positive leukemia cell line and patient primary leukemia cell.

Shi R, Lin J, Gong Y, Yan T, Shi F, Yang X, Liu X, Naren D. Shi R, et al. Among authors: yan t. Anticancer Drugs. 2015 Oct;26(9):913-22. doi: 10.1097/CAD.0000000000000266. Anticancer Drugs. 2015. PMID: 26186064

8

High Wilms' tumor 1 associating protein expression predicts poor prognosis in acute myeloid leukemia and regulates m⁶A methylation of MYC mRNA.

Naren D, Yan T, Gong Y, Huang J, Zhang D, Sang L, Zheng X, Li Y. Naren D, et al. Among authors: yan t. J Cancer Res Clin Oncol. 2021 Jan;147(1):33-47. doi: 10.1007/s00432-020-03373-w. Epub 2020 Sep 3. J Cancer Res Clin Oncol. 2021. PMID: 32880751

9

The m⁶A RNA methyltransferase METTL3/METTL14 promotes leukemogenesis through the mdm2/p53 pathway in acute myeloid leukemia.

Sang L, Wu X, Yan T, Naren D, Liu X, Zheng X, Zhang N, Wang H, Li Y, Gong Y. Sang L, et al. Among authors: yan t. J Cancer. 2022 Jan 4;13(3):1019-1030. doi: 10.7150/jca.60381. eCollection 2022. J Cancer. 2022. PMID: 35154467 Free PMC article.

10

Positive expression of PAX7 indicates poor prognosis of pediatric and adolescent AML patients.

Yan T, Naren D, Gong Y. Yan T, et al. Expert Rev Hematol. 2020 Mar;13(3):289-297. doi: 10.1080/17474086.2020.1719826. Epub 2020 Jan 28. Expert Rev Hematol. 2020. PMID: 31990602

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,220 results

Search Page

Filters